Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Nephrology |
| Therapuetic Areas: | Nephrology / Urology, Neurology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 2/7/2015 |
| Start Date: | February 2002 |
| End Date: | August 2013 |
| Contact: | Pedro Baron, MD |
| Email: | pbaron@llu.edu |
| Phone: | 909-558-3672 |
The purpose of this study is to evaluate the pathophysiology of nephrogenic fibrosing
dermopathy (NFD)/nephrogenic systemic fibrosis (NSF).
dermopathy (NFD)/nephrogenic systemic fibrosis (NSF).
Inclusion Criteria:
- People who have been diagnosed with NFD/NSF following a kidney transplant
- People who have been diagnosed with NFD/NSF following a liver transplant
- People with no NFD/NSF and who have not had a kidney or liver transplant
- People who have been diagnosed with NFD/NSF and who have not had a kidney or liver
transplant
We found this trial at
1
site
Loma Linda University Medical Center An outgrowth of the original Sanitarium on the hill in...
Click here to add this to my saved trials
